Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii

Octoprohibitin is a synthetic antimicrobial peptide (AMP), derived from the prohibitin-2 gene of Octopus minor. It showed substantial activity against multidrug resistant (MDR) Acinetobacter baumannii with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 200 and 400 µg/mL, respectively. Time-kill kinetics and bacterial viability assays confirmed the concentration-dependent antibacterial activity of octoprohibitin against A. baumannii. The morphology and ultrastructure of A. baumannii were altered by treatment with octoprohibitin at the MIC and MBC levels. Furthermore, propidium iodide-fluorescein diacetate (PI-FDA) staining and 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) staining of octoprohibitin-treated A. baumannii revealed membrane permeability alterations and reactive oxygen species (ROS) generation, respectively. Agarose gel retardation results confirmed the DNA-binding ability of octoprohibitin to the genomic DNA of A. baumannii. Furthermore, octoprohibitin showed concentration-dependent inhibition of biofilm formation and eradication. The minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) of octoprohibitin were 1000 and 1460 µg/mL, respectively. Octoprohibitin produced no significant cytotoxicity up to 800 µg/mL, and no hemolysis was observed up to 400 µg/mL. Furthermore, in vivo analysis in an A. baumannii-infected zebrafish model confirmed the effective bactericidal activity of octoprohibitin with higher cumulative survival percent (46.6%) and fewer pathological signs. Histological analysis showed reduced alterations in the gut, kidney, and gill tissues in the octoprohibitin-treated group compared with those in the phosphate-buffered saline (PBS)-treated group. In conclusion, our results suggest that octoprohibitin is a potential antibacterial and antibiofilm agent against MDR A. baumannii.

[1]  Muhammad Usman Munir,et al.  Nanomaterials Aiming to Tackle Antibiotic-Resistant Bacteria , 2022, Pharmaceutics.

[2]  Bagher BabaAli,et al.  Prediction of antimicrobial peptides toxicity based on their physico-chemical properties using machine learning techniques , 2021, BMC Bioinformatics.

[3]  I. Whang,et al.  Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii. , 2021, Fish & shellfish immunology.

[4]  I. Whang,et al.  Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii , 2021, International journal of molecular sciences.

[5]  E. Middelkoop,et al.  Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs) , 2021, Frontiers in Microbiology.

[6]  Muhammad Usman Munir,et al.  Recent Advances in Nanotechnology-Aided Materials in Combating Microbial Resistance and Functioning as Antibiotics Substitutes , 2020, International journal of nanomedicine.

[7]  Jehee Lee,et al.  Molecular insight into regulation of miRNA in the spleen of zebrafish (Danio rerio) upon pathogenic Streptococcus parauberis infection. , 2020, Fish & shellfish immunology.

[8]  P. Rather,et al.  Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis , 2020, Frontiers in Cellular and Infection Microbiology.

[9]  C. Wiart,et al.  Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates , 2020, BMC complementary medicine and therapies.

[10]  K. Ganbarov,et al.  Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance , 2020, Infection and drug resistance.

[11]  I. Whang,et al.  Octominin: A Novel Synthetic Anticandidal Peptide Derived from Defense Protein of Octopus minor , 2020, Marine drugs.

[12]  R. Lai,et al.  The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection , 2019, Proceedings of the National Academy of Sciences.

[13]  M. Yasir,et al.  Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability , 2019, bioRxiv.

[14]  Quan-yong He,et al.  The antimicrobial peptides and their potential clinical applications. , 2019, American journal of translational research.

[15]  M. Hof,et al.  Effect of helical kink in antimicrobial peptides on membrane pore formation , 2019, bioRxiv.

[16]  L. Chuang,et al.  Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation , 2019, Molecules.

[17]  Xilin Zhao,et al.  Post-stress bacterial cell death mediated by reactive oxygen species , 2019, Proceedings of the National Academy of Sciences.

[18]  You-Hee Cho,et al.  Antibacterial strategies inspired by the oxidative stress and response networks , 2019, Journal of Microbiology.

[19]  Yoonkyung Park,et al.  Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii , 2018, International journal of molecular sciences.

[20]  J. Hrenović,et al.  Survival of ESKAPE pathogen Acinetobacter baumannii in water of different temperatures and pH. , 2018, Water science and technology : a journal of the International Association on Water Pollution Research.

[21]  W. Kamysz,et al.  Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii , 2018, Probiotics and Antimicrobial Proteins.

[22]  R. Mirnejad,et al.  Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. , 2018, Microbial drug resistance.

[23]  R. Khanum,et al.  Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[24]  Heejun Choi,et al.  Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37 , 2017, PLoS pathogens.

[25]  T. Mah,et al.  Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. , 2017, FEMS microbiology reviews.

[26]  R. Gaur Antibiotic resistance: Alternative approaches , 2017, Indian journal of pharmacology.

[27]  Shamala Devi Sekaran,et al.  Intracellular Targeting Mechanisms by Antimicrobial Peptides , 2017, Antimicrobial Agents and Chemotherapy.

[28]  Jehee Lee,et al.  Green synthesis, physio-chemical characterization and anti-candidal function of a biocompatible chitosan gold nanocomposite as a promising antifungal therapeutic agent , 2017 .

[29]  David A. Phoenix,et al.  pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents , 2016, Pharmaceuticals.

[30]  G. Nataraj,et al.  Fluorescein diacetate vital staining for detecting viability of acid-fast bacilli in patients on antituberculosis treatment , 2016, International journal of mycobacteriology.

[31]  N. Waterhouse,et al.  Measuring Cell Death by Propidium Iodide Uptake and Flow Cytometry. , 2016, Cold Spring Harbor protocols.

[32]  Y. Lyu,et al.  Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida , 2016, Scientific Reports.

[33]  H. Aghamollaei,et al.  The development of antimicrobial peptides as an approach to prevention of antibiotic resistance , 2015 .

[34]  W. Blalock,et al.  Prohibitin 2: At a communications crossroads , 2015, IUBMB life.

[35]  L. Leibovici,et al.  Combination therapy for carbapenem-resistant Gram-negative bacteria. , 2014, The Journal of antimicrobial chemotherapy.

[36]  G. Durn,et al.  Occurrence of an Environmental Acinetobacter baumannii Strain Similar to a Clinical Isolate in Paleosol from Croatia , 2014, Applied and Environmental Microbiology.

[37]  R. Hancock,et al.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. , 2013, Nature chemical biology.

[38]  Yong-hui Shi,et al.  The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 , 2013, Journal of Microbiology.

[39]  K. Jolliffe,et al.  Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons , 2013, PloS one.

[40]  S. Amyes,et al.  The rise of carbapenem-resistant Acinetobacter baumannii. , 2012, Current pharmaceutical design.

[41]  Qihao Zhang,et al.  Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application , 2012, Peptides.

[42]  Timothy R. Walsh,et al.  Tackling antibiotic resistance , 2011, Nature Reviews Microbiology.

[43]  Chun Xing Li,et al.  Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. , 2011, Biotechnology advances.

[44]  Z. Aminzadeh,et al.  Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran , 2011, International journal of preventive medicine.

[45]  M. Adams,et al.  Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. , 2010, Surgical infections.

[46]  Oreola Donini,et al.  An anti-infective peptide that selectively modulates the innate immune response , 2007, Nature Biotechnology.

[47]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[48]  S. Bishop,et al.  De novo antimicrobial peptides with low mammalian cell toxicity. , 1996, Journal of medicinal chemistry.